OpenBilldrug price receipt

NADAC week of 2026-10-14

ATORVASTATIN 80 MG TABLET

For 30 tablets

Pharmacies pay

$2.08 filed

30 × $0.06926 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$4.36 filed

30 × $0.14518 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.1× estimated

Medicare paid 2.1× what pharmacies pay.

Part D averages every strength and form sold under “Atorvastatin Calcium” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$7.39 estimated

$2.08 + $0.31 (15%) + $5.00 fee per fill = $7.39

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ATORVASTATIN 80 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “atorvastatin calcium” and “atorvastatin calcium, film coated”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 26 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is HMG-CoA Reductase Inhibitor.

The NADAC file of 2026-10-14 prices it under 67 NDCs (National Drug Codes); the FDA directory lists 57 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $2.08 for 30 tablets (30 × $0.06926 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-10-07. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 26 labelers

LabelerNDCsPharmacies pay per unit
Dr. Reddy's Laboratories Inc7$0.06926 per EA filed
Laurus Labs Limited4$0.06926 per EA filed
NorthStar RxLLC4$0.06926 per EA filed
Camber Pharmaceuticals, Inc.3$0.06926 per EA filed
Macleods Pharmaceuticals Limited3$0.06926 per EA filed
Novadoz Pharmaceuticals LLC3$0.06926 per EA filed
Rising Pharma Holdings, Inc.3$0.06926 per EA filed
Apotex Corp.2$0.06926 per EA filed
Ascend Laboratories, LLC2$0.06926 per EA filed
Aurobindo Pharma Limited2$0.06926 per EA filed
Biocon Pharma Inc.2$0.06926 per EA filed
Lifestar Pharma LLC2$0.06926 per EA filed
Mylan Pharmaceuticals Inc.2$0.06926 per EA filed
NORTHSTAR RX LLC2$0.06926 per EA filed
ScieGen Pharmaceuticals, Inc.2$0.06926 per EA filed
Teva Pharmaceuticals USA, Inc.2$0.06926 per EA filed
Teva Pharmaceuticals, Inc.2$0.06926 per EA filed
Zydus Pharmaceuticals USA Inc.2$0.06926 per EA filed
American Health Packaging1$0.06926 per EA filed
AvPAK1$0.06926 per EA filed
Major Pharmaceuticals1$0.06926 per EA filed
Mylan Institutional Inc.1$0.06926 per EA filed
NIVAGEN PHARMACEUTICALS, INC.1$0.06926 per EA filed
Quallent1$0.06926 per EA filed
Quallent Pharmaceuticals Health LLC1$0.06926 per EA filed
Umedica Laboratories USA Inc.1$0.06926 per EA filed
Not listed as a package in the FDA directory10$0.06926 per EA filed

When these prices took effect

All 67 NDCs, with labeler and price
  • 00093-5057-05 · Teva Pharmaceuticals USA, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 00093-5057-98 · Teva Pharmaceuticals USA, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 00378-3953-05 · Mylan Pharmaceuticals Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 00378-3953-77 · Mylan Pharmaceuticals Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 00480-3588-10 · Teva Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 00480-3588-98 · Teva Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 00904-6293-04 · Major Pharmaceuticals · $0.06926 per EA · eff. 2026-09-23 filed
  • 16571-0139-09 · Rising Pharma Holdings, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 16571-0139-10 · Rising Pharma Holdings, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 16571-0139-50 · Rising Pharma Holdings, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 16714-0176-01 · NORTHSTAR RX LLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 16714-0176-03 · NORTHSTAR RX LLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 31722-0427-05 · Camber Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 31722-0427-10 · Camber Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 31722-0427-90 · Camber Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 33342-0318-10 · Macleods Pharmaceuticals Limited · $0.06926 per EA · eff. 2026-09-23 filed
  • 33342-0318-15 · Macleods Pharmaceuticals Limited · $0.06926 per EA · eff. 2026-09-23 filed
  • 33342-0318-44 · Macleods Pharmaceuticals Limited · $0.06926 per EA · eff. 2026-09-30 filed
  • 42385-0943-01 · Laurus Labs Limited · $0.06926 per EA · eff. 2026-09-23 filed
  • 42385-0943-05 · Laurus Labs Limited · $0.06926 per EA · eff. 2026-09-23 filed
  • 42385-0943-11 · Laurus Labs Limited · $0.06926 per EA · eff. 2026-09-23 filed
  • 42385-0943-90 · Laurus Labs Limited · $0.06926 per EA · eff. 2026-09-23 filed
  • 42571-0175-10 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
  • 42571-0175-90 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
  • 43598-0103-05 · Dr. Reddy's Laboratories Inc · $0.06926 per EA · eff. 2026-09-23 filed
  • 43598-0103-87 · Dr. Reddy's Laboratories Inc · $0.06926 per EA · eff. 2026-09-30 filed
  • 43598-0103-90 · Dr. Reddy's Laboratories Inc · $0.06926 per EA · eff. 2026-09-23 filed
  • 43598-0833-05 · Dr. Reddy's Laboratories Inc · $0.06926 per EA · eff. 2026-09-23 filed
  • 43598-0833-90 · Dr. Reddy's Laboratories Inc · $0.06926 per EA · eff. 2026-09-23 filed
  • 50228-0454-05 · ScieGen Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 50228-0454-90 · ScieGen Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 50268-0096-11 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
  • 50268-0096-12 · AvPAK · $0.06926 per EA · eff. 2026-09-23 filed
  • 51079-0211-01 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
  • 51079-0211-03 · Mylan Institutional Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 55111-0124-05 · Dr. Reddy's Laboratories Limited · $0.06926 per EA · eff. 2026-09-23 filed
  • 55111-0124-90 · Dr. Reddy's Laboratories Limited · $0.06926 per EA · eff. 2026-09-23 filed
  • 59651-0609-90 · Aurobindo Pharma Limited · $0.06926 per EA · eff. 2026-09-23 filed
  • 59651-0609-99 · Aurobindo Pharma Limited · $0.06926 per EA · eff. 2026-09-23 filed
  • 60290-0042-04 · Umedica Laboratories USA Inc. · $0.06926 per EA · eff. 2026-10-07 filed
  • 60505-2671-08 · Apotex Corp. · $0.06926 per EA · eff. 2026-09-23 filed
  • 60505-2671-09 · Apotex Corp. · $0.06926 per EA · eff. 2026-09-23 filed
  • 67877-0514-05 · Ascend Laboratories, LLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 67877-0514-90 · Ascend Laboratories, LLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 68084-0590-25 · American Health Packaging · $0.06926 per EA · eff. 2026-09-23 filed
  • 68084-0590-95 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
  • 68382-0252-10 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
  • 68382-0252-16 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
  • 70377-0030-12 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
  • 70377-0030-14 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
  • 70377-0080-11 · Biocon Pharma Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 70377-0080-13 · Biocon Pharma Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 70710-1770-00 · Zydus Pharmaceuticals USA Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 70710-1770-09 · Zydus Pharmaceuticals USA Inc. · $0.06926 per EA · eff. 2026-09-23 filed
  • 70756-0250-51 · Lifestar Pharma LLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 70756-0250-90 · Lifestar Pharma LLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 72205-0025-05 · Novadoz Pharmaceuticals LLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 72205-0025-90 · Novadoz Pharmaceuticals LLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 72205-0025-99 · Novadoz Pharmaceuticals LLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 72603-0285-01 · NorthStar RxLLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 72603-0285-02 · NorthStar RxLLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 72603-0285-03 · NorthStar RxLLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 72603-0406-01 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
  • 72603-0406-02 · NorthStar RxLLC · $0.06926 per EA · eff. 2026-09-23 filed
  • 75834-0258-01 · NIVAGEN PHARMACEUTICALS, INC. · $0.06926 per EA · eff. 2026-09-23 filed
  • 82009-0004-10 · Quallent · $0.06926 per EA · eff. 2026-09-23 filed
  • 82009-0179-10 · Quallent Pharmaceuticals Health LLC · $0.06926 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

7 other products in the NADAC file share an FDA nonproprietary name with ATORVASTATIN 80 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
ATORVASTATIN 10 MG TABLET
generic · tablet, film coated / tablet
$0.02283 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.14518 per EA filed
Part D 2024 average
ATORVASTATIN 20 MG TABLET
generic · tablet, film coated / tablet
$0.02792 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.14518 per EA filed
Part D 2024 average
ATORVASTATIN 40 MG TABLET
generic · tablet, film coated / tablet
$0.03743 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.14518 per EA filed
Part D 2024 average
ATORVASTATIN 80 MG TABLET this page
generic · tablet, film coated / tablet
$0.06926 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.14518 per EA filed
Part D 2024 average
LIPITOR 10 MG TABLET
brand · tablet, film coated
$13.40831 per EA filed
eff. 2026-09-23
$15.7092 per EA filed
Part D 2024 average
LIPITOR 20 MG TABLET
brand · tablet, film coated
$19.07256 per EA filed
eff. 2026-09-23
$15.7092 per EA filed
Part D 2024 average
LIPITOR 40 MG TABLET
brand · tablet, film coated
$19.11383 per EA filed
eff. 2026-09-23
$15.7092 per EA filed
Part D 2024 average
LIPITOR 80 MG TABLET
brand · tablet, film coated
$19.00394 per EA filed
eff. 2026-09-23
$15.7092 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 67 NDCs’ NADAC prices is $0.06926 per EA filed.

Of the 56 other products in FDA’s HMG-CoA Reductase Inhibitor class priced per EA, 40 have a higher middle NADAC price and 16 a lower one. The one in the middle is AMLODIPINE-ATORVAST 10-10 MG, at $0.97947 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $4.36 for 30 tablets, at an average of $0.14518 per EA in 2024 (2024-01-01 to 2024-12-31) for “Atorvastatin Calcium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 73,349,032 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ATORVASTATIN 80 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Atorvastatin Calcium / Atorvastatin Calcium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.